Skip to Main Content

Paper Details

Genomic landscape of advanced prostate cancer patients with BRCA1 versus BRCA2 mutations as detected by comprehensive genomic profiling of cell-free DNA.
Front Oncol
1
2022
-mutated prostate cancer, PARP, advanced prostate cancer, cell, cell-free, cell-free DNA, cfDNA, co-segregating genes, men, patients, poly (ADP-ribose), poly (ADP-ribose) polymerase, prostate cancer
Author NameAffiliation
Elisabeth I HeathBarbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine
Mark YandellUniversity of Utah
Mark YandellUniversity of Utah
Oliver SartorTulane Cancer Center, Tulane Medical School
Neeraj AgarwalHuntsman Cancer Institute, University of Utah
  • 1 - 5

Datasets

Release 1.2